Valuation: Arvee Laboratories (India) Ltd.

Market Cap 1.48B 15.47M 13.4M 12.55M 11.45M 21.53M 21.86M 148M 57.72M 739M 58.07M 56.81M 2.46B P/E 2024
151x
P/E 2025 72.9x
Enterprise Value 1.44B 15.06M 13.05M 12.23M 11.15M 20.96M 21.29M 144M 56.21M 719M 56.54M 55.32M 2.4B EV / Sales 2024
5.18x
EV / Sales 2025 3.96x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-2.20%
1 week+11.33%
Current month+10.60%
1 month+9.71%
3 months+3.18%
6 months+11.98%
Current year-18.75%
1 week 155.01
Extreme 155.01
189.39
1 month 147.15
Extreme 147.15
189.39
Current year 129.11
Extreme 129.11
208
1 year 129.11
Extreme 129.11
290.78
3 years 104
Extreme 104
315
5 years 62.9
Extreme 62.9
315
10 years 18.8
Extreme 18.8
315
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2014
Director of Finance/CFO 43 09/05/2018
Compliance Officer 35 14/02/2019
Director TitleAgeSince
Chairman 52 31/03/2014
Director/Board Member 43 11/08/2025
Director/Board Member 43 11/02/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%+11.33%+1.99%+54.22% 20.48M
-0.50%+3.42%+40.95%+40.27% 74.86B
-1.34%-1.60%+10.53%+8.93% 50.95B
-0.30%+0.61%+10.80%+33.70% 18.16B
-0.58%+3.48%+54.00%+85.08% 14.66B
-1.56%+3.59%+56.21%+42.46% 10.64B
-1.90%-7.21%+9.01%-15.78% 10.19B
-1.36%+0.19%+4.79% - 9.51B
+0.81%-1.11%-8.96%+13.29% 8.01B
-1.41%+2.50%+97.65%-30.73% 7.3B
Average -1.04%+3.39%+27.70%+25.71% 20.43B
Weighted average by Cap. -0.85%+2.69%+29.20%+28.25%

Financials

2024 2025
Net sales 303M 3.18M 2.76M 2.58M 2.36M 4.43M 4.5M 30.38M 11.87M 152M 11.95M 11.69M 507M 385M 4.04M 3.5M 3.28M 2.99M 5.62M 5.7M 38.53M 15.06M 193M 15.15M 14.82M 643M
Net income 10.52M 110K 95.55K 89.52K 81.65K 154K 156K 1.05M 412K 5.27M 414K 405K 17.56M 21.47M 225K 195K 183K 167K 313K 318K 2.15M 840K 10.75M 845K 827K 35.85M
Net Debt -8.65M -90.74K -78.62K -73.66K -67.19K -126K -128K -866K -339K -4.33M -341K -333K -14.45M -38.73M -406K -352K -330K -301K -565K -574K -3.88M -1.52M -19.39M -1.52M -1.49M -64.66M
Logo Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Limited is an India-based company. The Company is engaged in manufacturing of specialized chemicals. It operates through Textile and Non-Textile segments. It offers polymer modifiers, contrast media intermediates, and drug intermediates. Its polumer modifier products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, and 5-Sodiosulfo-Bis-Isophthalate. Its contrast media intermediate products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, 3,5-Dinitrobenzoic Acid, and 3,5-Diamino Benzoic Acid. Its drug intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine, and 2-Chloro-5-Nitrobenzoic Acid.
Employees
-
Date Price Change Volume
13/08/26 173.34 -2.20% 3,182
12/08/26 ₹177.24 +0.27% 17,422
11/08/26 ₹176.76 +13.97% 77,723
10/08/26 ₹155.10 -0.91% 6,390
07/08/26 ₹156.52 +0.53% 872
  1. Stock Market
  2. Stocks
  3. ARVEE Stock